Meridian Bioscience Inc. (NASDAQ:VIVO) Posts Basic Consolidated EPS Of $0.8531

0

Meridian Bioscience Inc. (NASDAQ:VIVO)managed to report annual basic consolidated EPS of $0.8531, which was for the year ended2015-09-30.The company reported basic consolidated EPS of $0.8531 for the quarter ended 2015-09-30.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-09-30. As for the quarter ended 2015-09-30, continuing operations produced EPS of $0.2081.

EPS contribution from parent

Meridian Bioscience Inc. (NASDAQ:VIVO) received of $0.8531 EPS boost from the parent company for the annual period ended

For the year ended 2015-09-30, the parent of Meridian Bioscience Inc. (NASDAQ:VIVO) contributed EPS of $0.8531 to the company’s bottom-line. But for the quarter ended 2015-09-30, EPS boost from the parent was cited as $0.8531.

What About Basic net EPS

The basic net EPS that Meridian Bioscience Inc. (NASDAQ:VIVO) reported for the year ended 2015-09-30 stood at $0.85. For the quarter ended 2015-09-30, the company posted basic net EPS of $0.85.

What About Consolidated Diluted EPS?

Meridian Bioscience Inc. (NASDAQ:VIVO)’s consolidated diluted EPS for the year ended 2015-09-30 was reported as $0.8459. For the quarter ended 2015-09-30 the metric was$0.8459.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $0.8459 for the yearended 2015-09-30. But diluted EPS from continuing operations for the quarter ended 2015-09-30 came in at $0.8459.

Net diluted EPS

Net diluted EPS posted by Meridian Bioscience Inc. (NASDAQ:VIVO) for the year ended 2015-09-30 was $0.85. On quarterly basis, net diluted EPS for the quarter ended 2015-09-30 was reported as $0.85.

What portion of diluted EPS came from parent?

For the annual period ended 2015-09-30, the parent company of Meridian Bioscience Inc. (NASDAQ:VIVO) said that it parent company boosted its diluted EPS by$0.8459 in the year ended 2015-09-30. For the quarter ended 2015-09-30, the parent company’s contribution to diluted EPS was $0.8459.

The company reported net basic EPS of $0.85 for the year ended 2015-09-30 and net basic EPS of $0.85 for the quarter ended 2015-09-30.

The number of Meridian Bioscience Inc. (NASDAQ:VIVO)’s basic shares outstanding at the end of the annual period ended 2015-09-30 was 41.659. That compares with 41.659 basic shares outstanding for the quarter ended 2015-09-30.

Meridian Bioscience Inc. (NASDAQ:VIVO) had 42.012 diluted shares outstanding at the end of the annual period ended 2015-09-30. But for the quarter ended 2015-09-30, diluted outstanding shares were 42.012.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)